Cinacalcet Hydrochloride Tablets: recall status
⚠ Recalls found. Cinacalcet Hydrochloride Tablets is named in 3 official recalls in our current data:
- Brand
- Cipla USA
Recalls naming this model
FDA Class II · Drug · July 8, 2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Company / brand: Cipla USA
Affected product: Cinacalcet Hydrochloride Tablets
Official ID D-0661-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Company / brand: Cipla USA
Affected product: Cinacalcet Hydrochloride Tablets
Official ID D-0675-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Company / brand: Cipla USA
Affected product: Cinacalcet Hydrochloride Tablets
Official ID D-0676-2026 ·
Official record ↗
See all Cipla USA recalls →
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.